Thyroid biopsy Doctors Abroad — Page 3

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Shady Mohammed El-sebai is the Chief of Interventional Radiology at the National Cancer Institute, Cairo University. He specializes in oncology-focused imaging and minimally invasive procedures. Dr. El-sebai treats liver, renal, and soft-tissue tumors using chemoembolization and ablation techniques. He works at Shef Al Orman Oncology Hospital, an ESMO-accredited center.

• Performs microwave and radiofrequency ablation for bone, lung, and thyroid lesions.
• Expert in US- and CT-guided biopsies, including Mammotome breast lesion excision.
• Specializes in uterine artery embolization for fibroids and varicose vein ablation.
• Manages complex biliary and renal cases with percutaneous stenting and drainage.

The doctor is an experienced specialist in interventional radiology, with a dedicated clinical focus on thyroid and prostate imaging and interventions. With a strong academic foundation from Istanbul University Cerrahpaşa Faculty of Medicine and specialized residency training in radiology at S.B. Haydarpaşa Numune Training and Research Hospital, the doctor brings extensive expertise to the field.

Throughout a distinguished career, the doctor has contributed to clinical practice at institutions including Başkent University Istanbul Hospital and S.B. Haydarpaşa Numune Training and Research Hospital. Additionally, the doctor holds a background in healthcare management from Anadolu University and maintains active professional memberships with the Istanbul Medical Chamber and the Istanbul Radiology Society.

The doctor is a highly versatile radiologist with extensive expertise across a broad spectrum of diagnostic and interventional imaging modalities. Clinical proficiency includes abdomen, Doppler, obstetric, breast, musculoskeletal, pediatric, and neuroradiology, ensuring comprehensive diagnostic support for diverse patient populations.

In addition to diagnostic imaging, the doctor is skilled in performing nonvascular interventional procedures, providing minimally invasive solutions to complex clinical conditions. This multidisciplinary approach allows for precise diagnostic accuracy and effective therapeutic intervention across various medical specialties.

The doctor is a highly specialized surgeon with extensive expertise in oncological and metabolic procedures. The clinical focus encompasses a wide range of cancer surgeries, including complex interventions for pancreatic, bile duct, gastric, colon, and thyroid malignancies, as well as specialized breast surgery.

In addition to oncology, the doctor is proficient in bariatric and metabolic surgery, providing advanced surgical solutions for obesity and diabetes management. The practice is dedicated to delivering comprehensive surgical care, utilizing evidence-based techniques to address both malignant conditions and metabolic health disorders.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Serkan Deveci is a urologist and oncosurgeon at Medical Park Göztepe Hospital, Istanbul. He specializes in treating prostate, kidney, and testicular cancers. Dr. Deveci holds a professorship and is a member of the American Urology Association. He has authored over 20 international publications on sexual medicine and uro-oncology.

• Expertise includes nephrectomy and specialized biopsy procedures for various conditions.
• Section Editor for UpToDate, a clinical decision support resource used worldwide.
• Member of the American Urological Association abstract reviewer team.
• Practices at JCI-accredited Medical Park Göztepe, which holds a Robotic Surgery Center certification.

The doctor is a gynecologist specializing in endoscopic and laparoscopic operations. With a focus on minimally invasive surgical techniques, the doctor is skilled in performing advanced procedures that enhance patient recovery and outcomes. The doctor has extensive experience in handling complex gynecological cases, utilizing cutting-edge technology to provide optimal care.

Professor Moshe Papa heads the surgical department at Assuta Medical Center. He brings senior surgical expertise to cases requiring a thyroid biopsy.

• Serves as a professor at Tel Aviv University medical faculty
• Former surgeon and researcher at the National Institutes of Health in the US
• Leads complex surgical procedures and diagnostic evaluations at Israel Central Hospital
• Coordinates care within a specialized surgical department for precise results

Professor Yoram Kluger is a specialist in surgical oncology at Rambam Medical Center. He performs surgical procedures and provides expert evaluations for patients needing a thyroid biopsy.

• Serves as a Professor of Surgery at a leading medical university
• Focuses on oncosurgery to treat cancerous and non-cancerous tumors
• Provides high-level diagnostic care for patients with suspected thyroid issues

Dr. Karen Drumea is a senior specialist at Rambam Medical Center. She focuses on oncology and radiotherapy during thyroid biopsy evaluations.

• Expert in medical oncology – treats various types of cancer with specialized therapies
• Senior specialist at Rambam Medical Center – a leading state hospital in Israel
• Certified in radiotherapy – uses targeted radiation for precise cancer treatment

The doctor is a distinguished oncosurgeon with extensive experience in urology. Specializing in advanced surgical techniques, the doctor has significantly contributed to the field of urologic oncology. With a focus on minimally invasive procedures, the doctor has successfully performed numerous complex surgeries, improving patient outcomes. The doctor is also actively involved in clinical research, contributing to several peer-reviewed publications and presenting findings at international conferences.

The doctor is an accomplished oncogynecologist with extensive experience in treating gynecological cancers. Specializing in advanced surgical techniques and personalized treatment plans, the doctor has contributed significantly to improving patient outcomes. With numerous publications in peer-reviewed journals, the doctor is recognized for expertise in minimally invasive procedures and has been a keynote speaker at international conferences.

The doctor holds board certification in gynecologic oncology and is actively involved in clinical research, focusing on innovative therapies and early detection methods. The doctor is affiliated with a leading medical institution and collaborates with multidisciplinary teams to provide comprehensive care.

Dr. Lee Kyu Taek is a gastroenterologist at Samsung Medical Center in Seoul. He specializes in treating pancreatic, bile duct, and gallbladder cancers. Dr. Lee serves as a professor at the Department of Gastroenterology. He trained at Stanford University School of Medicine in the United States.

• Expertise in surgical oncology procedures like Whipple surgery.
• Performs distal pancreatectomy and complex pancreatic biopsies.
• Completed medical training in South Korea, Japan, and the USA.
• Member of the Korean Society of Gastrointestinal Endoscopy.

Professor Ahn Jin Seok is a senior oncologist at Samsung Medical Center. He brings high-level clinical expertise to diagnostic procedures like thyroid biopsy.

• Serves as a professor at the Sungkyunkwan University School of Medicine
• Practices at Samsung Medical Center – a top-ranked hospital in South Korea
• Focuses on oncology – the study and treatment of tumors
• Works within a leading academic medical system to ensure accurate cancer diagnostics

The doctor is a highly skilled gynecologist with a specialized focus in oncogynecology, providing expert care in the diagnosis and treatment of gynecological cancers. With extensive experience in both surgical and non-surgical approaches, the doctor is committed to advancing women's health through innovative treatments and compassionate care.

The doctor is an accomplished oncosurgeon with extensive experience in urology. As the Head of the Samsung Department of Urology, the doctor has led numerous innovative surgical procedures and contributed to significant advancements in the field. The doctor is recognized for expertise in minimally invasive techniques and has been instrumental in developing new protocols for cancer treatment. The doctor is highly regarded for a commitment to patient care and has received multiple accolades for contributions to medical research and education.